• Price (USD)18.50
  • Today's Change-0.10 / -0.54%
  • Shares traded4.47m
  • 1 Year change16.06%
  • Beta0.6186
Data delayed at least 15 minutes, as of Dec 13 2019 21:00 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Ares Capital Corporation is a specialty finance company. The Company operates as a closed-end, non-diversified management investment company. The Company's investment objective is to generate both current income and capital appreciation through debt and equity investments. It invests primarily in the United States middle-market companies. It may from time to time invest in larger or smaller (in particular, for investments in early-stage and/or venture capital-backed) companies. It invests primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and mezzanine debt, generally in a first lien position), second lien senior secured loans, and mezzanine debt, which in some cases includes an equity component. It invests in various industries, such as automotive services, business services, consumer products, and containers and packaging. Ares Capital Management LLC serves as its investment advisor.

  • Revenue in USD (TTM)1.49bn
  • Net income in USD742.00m
  • Incorporated2004
  • Employees1.00k
  • Location
    Ares Capital Corp245 Park Ave Fl 44NEW YORK 10167-4400United StatesUSA
  • Phone+1 (212) 750-7300
  • Fax+1 (212) 750-1777
  • Websitehttp://www.arescapitalcorp.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
iShares Silver Trust (ETF)0.00-828.45m6.20bn0.00--1.16-----2.38-2.380.0013.700.00-------15.551.58-15.561.58--23.86--286.08---0.03310.000.00-100.00--36.89------
iShares S&P MidCap 400 Value Index (ETF)56.95m589.58m6.55bn--8.080.9841--115.1020.8720.871.84171.450.0117--12.97--12.1113.1713.0614.0879.6585.431,035.32849.82----0.0011.44-8.728.71-10.08-5.10--10.20
iShares S&P SmallCap 600 Value Idx (ETF)55.58m203.14m6.66bn--28.841.34--119.875.535.531.90118.820.0151--8.81--5.5110.916.0912.1285.8285.39365.47766.63----0.0011.5525.3618.32-69.62-21.27--16.97
iShares Russell 3000 Value Index (ETF)17.40m58.78m6.84bn--7.101.39--393.058.788.782.6444.940.0231--9.03--7.8011.637.9611.8995.0391.78337.83500.20----0.0018.4242.8514.45-40.48-16.82--39.12
Sarossa PLC4.01m3.58m6.93bn4.002,636.31335.89--1,729.010.00570.00570.00640.04470.1684--9.661,002,039.0015.04-51.5215.12-56.68----89.33-770.99----0.00--24.81-31.77-27.18------
iShares S&P MidCap 400 Growth (ETF)56.95m589.58m7.48bn--12.881.37--131.3118.1718.171.84171.450.0105--19.16--10.8512.5211.8213.65----1,035.321,339.57----0.006.2013.3726.44-25.22-6.97--25.18
iShares NASDAQ Biotechnology Index (ETF)30.14m2.29bn7.59bn--1.811.05--251.7466.7966.790.6819114.570.0039--5.63--29.6126.5734.1830.88----7,595.886,344.19----0.000.473474.3138.9972.8738.81----
Alerian MLP0.00824.24m7.62bn--3.940.4597----
iShares Russell 3000 Growth Index (ETF)8.30m76.59m7.64bn--6.441.64--920.4810.3410.341.1540.550.0151--6.15--13.9313.4014.4413.8292.4987.31922.61843.10----0.0010.4415.918.81-14.61-10.34--31.80
Ares Capital Corporation1.49bn742.00m7.90bn1.00k10.631.07--5.311.741.743.4917.270.1113--10.661,487,000.005.565.815.745.9756.7653.2649.9053.75--10.230.472392.8015.268.6828.6411.92---1.01
Vanguard Financials ETF411.05m408.97m7.95bn--9.381.55--19.348.128.128.1249.320.1856------18.4617.4418.4617.44----99.49108.85----0.0010.8022.9588.4122.90----3.34
iShares Lehman Intermdte Credit Bnd(ETF)159.39m203.34m9.54bn--24.281.05--59.832.392.391.8655.150.0242--2.15--3.09--3.35--92.49--127.58------0.00---1.86--371.21------
Vanguard Small-Cap Growth ETF155.27m152.42m9.55bn--38.641.55--61.495.065.065.01125.880.0412------4.047.634.047.63----98.17401.91----0.0011.28469.2294.55513.25-15.30--39.55
Vanguard Health Care ETF728.15m724.43m9.61bn--9.861.43--13.2019.1319.1316.54132.340.1592------15.8422.4415.8422.44----99.4999.55----0.004.89-9.68132.74-9.83138.50---5.24
iShares Russell 2000 Growth Index (ETF)64.80m776.03m9.63bn--15.281.39--148.5913.8113.811.34151.620.0079--14.68--9.4110.7311.3412.6975.2177.241,197.501,202.74----0.007.0117.6319.07-41.31-9.88--21.25
iShares Russell 2000 Value Index (ETF)110.82m227.29m9.73bn--30.191.36--87.834.204.201.9393.570.0174--2.68--3.5616.644.0718.7986.9388.49205.09895.90----0.0010.59-0.63755.7652.06----6.62
Data as of Dec 13 2019. Currency figures normalised to Ares Capital Corp's reporting currency: US Dollar USD
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.